Information
-
Trademark
-
79287488
-
International Classifications
-
Filing Date
December 05, 2019
5 years ago
-
Transaction Date
February 27, 2022
2 years ago
-
Status Date
February 05, 2021
3 years ago
-
Location Date
February 05, 2021
3 years ago
-
Status Code
602
-
Current Location
TMO LAW OFFICE 125 - EXAMINING ATTORNEY ASSIGNED
Employee Name
CARR, PATRICK CLAYTON
-
Law Office Assigned Location Code
N70
-
Owners
Mark Drawing Code
4000
Mark Identification
BIO-COURIER
Case File Statements
- GS0051: Chemicals and chemical preparations for medical, veterinary and pharmaceutical purposes; chemicals and chemical preparations for medical, veterinary and pharmaceutical research purposes; chemicals and chemical preparations for medical, veterinary and pharmaceutical treatment purposes; biochemical substances and biochemical preparations for medical, veterinary and pharmaceutical purposes; biochemical substances and biochemical preparations for medical, veterinary and pharmaceutical research purposes; biochemical substances and biochemical preparations for medical, veterinary and pharmaceutical treatment purposes; biological substances and biological preparations for medical, veterinary and pharmaceutical purposes; biological substances and biological preparations for medical, veterinary and pharmaceutical research purposes; biological substances and biological preparations for medical, veterinary and pharmaceutical treatment purposes; nanoparticle substances and nanoparticle preparations for medical, veterinary and pharmaceutical purposes; nanoparticle substances and nanoparticle preparations for medical, veterinary and pharmaceutical research purposes; nanoparticle substances and nanoparticle preparations for medical, veterinary and pharmaceutical treatment purposes; preparations of trace elements for human and animal use; silicon for medical, veterinary and pharmaceutical purposes; silicon nanoparticle materials for medical, veterinary and pharmaceutical purposes; porous silicon nanoparticle materials for medical, veterinary and pharmaceutical purposes; pharmaceutical preparations for carrying and delivery of chemical, biochemical, biological and pharmaceutical substances; pharmaceutical nanoparticle preparations for carrying and delivery of chemical, biochemical, biological and pharmaceutical substances; pharmaceutical silicon nanoparticle preparations for carrying and delivery of chemical, biochemical, biological and pharmaceutical substances; pharmaceutical porous silicon nanoparticle preparations for carrying and delivery of chemical, biochemical, biological and pharmaceutical substances; pharmaceutical preparations for carrying and delivery of chemical, biochemical, biological and pharmaceutical substances for vaccines; pharmaceutical nanoparticle preparations for carrying and delivery of chemical, biochemical, biological and pharmaceutical substances for vaccines; pharmaceutical silicon nanoparticle preparations for carrying and delivery of chemical, biochemical, biological and pharmaceutical substances for vaccines; pharmaceutical porous silicon nanoparticle preparations for carrying and delivery of chemical, biochemical, biological and pharmaceutical substances for vaccines; pharmaceutical preparations for carrying and delivery of chemical, biochemical, biological and pharmaceutical substances for antiseptics; pharmaceutical nanoparticle preparations for carrying and delivery of chemical, biochemical, biological and pharmaceutical substances for antiseptics; pharmaceutical silicon nanoparticle preparations for carrying and delivery of chemical, biochemical, biological and pharmaceutical substances for antiseptics; pharmaceutical porous silicon nanoparticle preparations for carrying and delivery of chemical, biochemical, biological and pharmaceutical substances for antiseptics; pharmaceutical preparations for carrying and delivery of chemical, biochemical, biological and pharmaceutical substances for antibiotics; pharmaceutical nanoparticle preparations for carrying and delivery of chemical, biochemical, biological and pharmaceutical substances for antibiotics; pharmaceutical silicon nanoparticle preparations for carrying and delivery of chemical, biochemical, biological and pharmaceutical substances for antibiotics; pharmaceutical porous silicon nanoparticle preparations for carrying and delivery of chemical, biochemical, biological and pharmaceutical substances for antibiotics; pharmaceutical preparations for carrying and delivery of chemical, biochemical, biological and pharmaceutical substances for dermatological treatment preparations; pharmaceutical nanoparticle preparations for carrying and delivery of chemical, biochemical, biological and pharmaceutical substances for dermatological treatment preparations; pharmaceutical silicon nanoparticle preparations for carrying and delivery of chemical, biochemical, biological and pharmaceutical substances for dermatological treatment preparations; pharmaceutical porous silicon nanoparticle preparations for carrying and delivery of chemical, biochemical, biological and pharmaceutical substances for dermatological treatment preparations; pharmaceutical preparations for carrying and delivery of chemical, biochemical, biological and pharmaceutical substances for skin care preparations; pharmaceutical nanoparticle preparations for carrying and delivery of chemical, biochemical, biological and pharmaceutical substances for skin care preparations; pharmaceutical silicon nanoparticle preparations for carrying and delivery of chemical, biochemical, biological and pharmaceutical substances for skin care preparations; pharmaceutical porous silicon nanoparticle preparations for carrying and delivery of chemical, biochemical, biological and pharmaceutical substances for skin care preparations; pharmaceutical preparations for carrying and delivery of chemical, biochemical, biological and pharmaceutical substances for drug delivery devices; pharmaceutical nanoparticle preparations for carrying and delivery of chemical, biochemical, biological and pharmaceutical substances for drug delivery devices; pharmaceutical silicon nanoparticle preparations for carrying and delivery of chemical, biochemical, biological and pharmaceutical substances for drug delivery devices; pharmaceutical porous silicon nanoparticle preparations for carrying and delivery of chemical, biochemical, biological and pharmaceutical substances for drug delivery devices; pharmaceutical preparations for stabilising of chemical, biochemical, biological and pharmaceutical substances; pharmaceutical nanoparticle preparations for stabilising of chemical, biochemical, biological and pharmaceutical substances; pharmaceutical silicon nanoparticle preparations for stabilising of chemical, biochemical, biological and pharmaceutical substances; pharmaceutical porous silicon nanoparticle preparations for stabilising of chemical, biochemical, biological and pharmaceutical substances; pharmaceutical preparations for controlled release and onset of chemical, biochemical, biological and pharmaceutical substances; pharmaceutical nanoparticle preparations for controlled release and onset of chemical, biochemical, biological and pharmaceutical substances; pharmaceutical silicon nanoparticle preparations for controlled release and onset of chemical, biochemical, biological and pharmaceutical substances; pharmaceutical porous silicon nanoparticle preparations for controlled release and onset of chemical, biochemical, biological and pharmaceutical substances
- GS0011: Chemicals and chemical preparations for use in industry, science and research; biochemical substances and biochemical preparations for use in industry, science and research; biological substances and biological preparations for use in industry, science and research; nanoparticle substances and nanoparticles for use in industry, science and research; silicon for use in industry, science and research; silicon nanoparticle materials for use in industry, science and research; porous silicon nanoparticle materials for use in industry, science and research; chemical materials for carrying and delivery of chemical, biochemical and biological substances; nanoparticle materials for carrying and delivery of chemical, biochemical and biological substances; silicon nanoparticle materials for carrying and delivery of chemical, biochemical and biological substances; porous silicon nanoparticle materials for carrying and delivery of chemical, biochemical and biological substances; chemical materials for carrying and delivery of chemical, biochemical and biological substances for use in the manufacture of cosmetics; nanoparticle materials for carrying and delivery of chemical, biochemical and biological substances for use in the manufacture of cosmetics; silicon nanoparticle materials for carrying and delivery of chemical, biochemical and biological substances for use in the manufacture of cosmetics; porous silicon nanoparticle materials for carrying and delivery of chemical, biochemical and biological substances for use in the manufacture of cosmetics; chemical materials for carrying and delivery of chemical, biochemical and biological substances for skin care preparations; nanoparticle materials for carrying and delivery of chemical, biochemical and biological substances for skin care preparations; silicon nanoparticle materials for carrying and delivery of chemical, biochemical and biological substances for skin care preparations; porous silicon nanoparticle materials for carrying and delivery of chemical, biochemical and biological substances for skin care preparations; chemical materials for stabilising of chemical, biochemical and biological substances; nanoparticle materials for stabilising of chemical, biochemical and biological substances; silicon nanoparticle materials for stabilising of chemical, biochemical and biological substances; porous silicon nanoparticle materials for stabilising of chemical, biochemical and biological substances
Case File Event Statements
-
2/27/2022 - 2 years ago
17 - FINAL DECISION TRANSACTION PROCESSED BY IB
Type: FINT
-
2/7/2022 - 2 years ago
16 - FINAL DISPOSITION NOTICE SENT TO IB
Type: FICS
-
2/5/2022 - 2 years ago
15 - FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Type: FICR
-
12/5/2021 - 3 years ago
14 - NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Type: OPNX
-
11/17/2021 - 3 years ago
13 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Type: OPNS
-
11/17/2021 - 3 years ago
12 - NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Type: OPNR
-
2/5/2021 - 3 years ago
11 - ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Type: MAB2
-
2/5/2021 - 3 years ago
10 - ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Type: ABN2
-
8/14/2020 - 4 years ago
9 - REFUSAL PROCESSED BY IB
Type: RFNT
-
7/25/2020 - 4 years ago
8 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Type: RFCS
-
7/25/2020 - 4 years ago
7 - REFUSAL PROCESSED BY MPU
Type: RFRR
-
6/21/2020 - 4 years ago
6 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Type: RFCR
-
6/20/2020 - 4 years ago
5 - NON-FINAL ACTION WRITTEN
Type: CNRT
-
6/19/2020 - 4 years ago
4 - APPLICATION FILING RECEIPT MAILED
Type: MAFR
-
6/15/2020 - 4 years ago
3 - ASSIGNED TO EXAMINER
Type: DOCK
-
6/15/2020 - 4 years ago
2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Type: NWOS
-
6/11/2020 - 4 years ago
1 - SN ASSIGNED FOR SECT 66A APPL FROM IB
Type: REPR